CLSI NBS06-A PDF
Product Code:
Availability:
Availability:
product
In Stock
In Stock
$99.00
$180.00
IN TAX $99.00
IN TAX $99.00
Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline, NBS06AE
Published by | Publication Date | Number of Pages |
CLSI | 04/01/2013 | 92 |
CLSI NBS06-A – Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline, NBS06AE
This document addresses the detection of severe combined immunodeficiency (SCID) by population-based newborn screening using dried blood spot specimens to measure T-cell receptor excision circles. SCID is a lethal disorder of infancy that is not evident at birth, and effective treatment requires presymptomatic detection.
Reviews (0)